Suzano (SUZB3) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
1 Apr, 2026Financial performance and governance
Net revenue reached US$9.0 billion in 2025, with adjusted EBITDA of US$3.9 billion and a 43% margin.
Net debt stood at US$12.6 billion, with net leverage at 3.2x.
Board of Directors includes 44% independent members and 22% women, supported by multiple committees.
Listed on B3's Novo Mercado and NYSE ADR Level 2, reflecting strong governance standards.
Asset base and operational scale
Manages 1.7 million hectares of planted and certified areas, with 9 pulp mills and 4 export ports.
Market pulp capacity of 13.4 million tons and paper production of 1.6 million tons.
Integrated supply chain with 10 dedicated vessels, serving 74 countries.
Holds ~41% share of the Brazilian paper market and operates a unique go-to-market model.
Market dynamics and competitive positioning
Brazil leads global hardwood pulp production, with significant cost advantages over other regions.
Ongoing pulp capacity expansions in Latin America and Asia, with new integrated capacity in China.
Strategic focus on reducing operational disbursement, disciplined growth, and deleveraging to below 2.5x.
Latest events from Suzano
- Record sales, cost reductions, and strong liquidity support a positive 2026 outlook.SUZB3
Q4 202511 Apr 2026 - EBITDA up 60% year-over-year, but net loss of R$3.77B on FX and derivative impacts.SUZB3
Q2 20241 Feb 2026 - EBITDA and sales volumes surged, with Ribas ramp-up and acquisitions boosting performance.SUZB3
Q3 202418 Jan 2026 - Cost leadership, operational excellence, and disciplined capital allocation drive growth.SUZB3
Investor Day 202411 Jan 2026 - Record sales and EBITDA driven by Ribas ramp-up, but FX losses led to a net loss.SUZB3
Q4 20248 Jan 2026 - Focus is on competitiveness, cost reduction, and disciplined growth amid market shifts.SUZB3
Investor Day 202512 Dec 2025 - Strong sales growth, robust cash flow, and major strategic moves marked the quarter.SUZB3
Q2 202523 Nov 2025 - Net income rose to R$6.3B in 1Q25, with stable leverage and strong free cash flow.SUZB3
Q1 202518 Nov 2025 - JV creates a global tissue leader with $3.3bn revenue, $175M synergies, and strong diversification.SUZB3
Investor Update12 Nov 2025